Suskind Dennis 4

What Happened

• Dennis Suskind, a director of CME Group Inc. (CME), was granted 645 shares of Class A common stock on 2026-06-25. The shares were issued at $225.00 per share for a total value of $145,125. This was an award/grant (reported as transaction code A) issued as director compensation, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-25; Price per share: $225.00; Total value: $145,125.
• Transaction type: Award/Grant (A) — acquisition through the CME Group Director Stock Plan.
• Shares are fully vested on grant (per footnote): no vesting conditions apply.
• Shares owned after the transaction: not specified in the filing.
• Filing date: 2026-06-29 — filed within the typical Form 4 reporting window (timely).

Context

• This award appears to be routine equity compensation for non-employee directors under CME’s Director Stock Plan and does not indicate a market sale or purchase by the director. Because the shares are fully vested at grant, there are no future service-based vesting conditions attached. Routine director awards are common and reflect compensation rather than a direct investment decision by the insider.